Despite FLT3 circumvention, STAT5 and MAPK downstream pathways are kept active in some mutated FLT3 AML cases, proposing counteractive mechanisms such as FLT3-independent triggering STAT5 and MAPK pathways [31]. Here, FLT3 is linked to acute myeloid leukemia.